Bioleaders Corporation (142760) — Financial Flexibility Index
Bioleaders Corporation (142760) has a Financial Flexibility Index of -0.11x as of June 2026. Free cash flow of ₩-887.44 Million (operating CF ₩-932.70 Million minus capex ₩45.26 Million) represents 0% of total liabilities (₩8.29 Billion). Check cash flow reinvestment rate of Bioleaders Corporation to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bioleaders Corporation Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Bioleaders Corporation across 11 annual periods. For the full cash flow conversion analysis, see 142760 cash flow metrics.
Annual Financial Flexibility Index for Bioleaders Corporation (2015–2025)
Year-by-year free cash flow to debt coverage for Bioleaders Corporation. Explore 142760 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.48x | ₩-5.76 Billion | ₩-5.97 Billion | ₩12.04 Billion | ▼ -2260.6% |
| 2024 | 0.02x | ₩551.95 Million | ₩-501.75 Million | ₩24.94 Billion | ▼ -95.5% |
| 2023 | 0.49x | ₩6.55 Billion | ₩6.18 Billion | ₩13.28 Billion | ▲ +431.2% |
| 2022 | -0.15x | ₩-18.89 Billion | ₩-20.60 Billion | ₩126.73 Billion | ▼ -555.3% |
| 2021 | -0.02x | ₩-3.27 Billion | ₩-5.04 Billion | ₩143.74 Billion | ▼ -129.5% |
| 2020 | 0.08x | ₩12.36 Billion | ₩-5.43 Billion | ₩160.09 Billion | ▼ -55.0% |
| 2019 | 0.17x | ₩21.31 Billion | ₩-2.20 Billion | ₩124.30 Billion | ▲ +572.5% |
| 2018 | -0.04x | ₩-4.71 Billion | ₩-8.77 Billion | ₩129.79 Billion | ▲ +98.5% |
| 2017 | -2.46x | ₩-5.94 Billion | ₩-8.53 Billion | ₩2.41 Billion | ▼ -63.3% |
| 2016 | -1.51x | ₩-6.26 Billion | ₩-7.70 Billion | ₩4.15 Billion | ▼ -35.0% |
| 2015 | -1.12x | ₩-4.45 Billion | ₩-4.83 Billion | ₩3.99 Billion | — |